Ergomed Dividends and Buybacks
Dividend criteria checks 0/6
Ergomed does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-0.04%
Buyback Yield
| Total Shareholder Yield | -0.04% |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Is It Time To Consider Buying Ergomed plc (LON:ERGO)?
Aug 19
At UK£9.74, Is Ergomed plc (LON:ERGO) Worth Looking At Closely?
Apr 12Ergomed plc (LON:ERGO) Shares Could Be 21% Below Their Intrinsic Value Estimate
Oct 29Should You Be Adding Ergomed (LON:ERGO) To Your Watchlist Today?
Jul 14Why Ergomed plc (LON:ERGO) Could Be Worth Watching
Jun 12Calculating The Fair Value Of Ergomed plc (LON:ERGO)
Apr 07Does Ergomed (LON:ERGO) Deserve A Spot On Your Watchlist?
Mar 19Why Ergomed plc (LON:ERGO) Could Be Worth Watching
Mar 01Calculating The Fair Value Of Ergomed plc (LON:ERGO)
Dec 15I Ran A Stock Scan For Earnings Growth And Ergomed (LON:ERGO) Passed With Ease
Nov 24Calculating The Intrinsic Value Of Ergomed plc (LON:ERGO)
Aug 28If You Like EPS Growth Then Check Out Ergomed (LON:ERGO) Before It's Too Late
Jul 31Getting In Cheap On Ergomed plc (LON:ERGO) Might Be Difficult
Jul 06Ergomed plc (LON:ERGO) Shares Could Be 31% Above Their Intrinsic Value Estimate
May 21Do Ergomed's (LON:ERGO) Earnings Warrant Your Attention?
Mar 26If You Had Bought Ergomed (LON:ERGO) Stock Five Years Ago, You Could Pocket A 643% Gain Today
Feb 22Has Ergomed plc's (LON:ERGO) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Jan 18Ergomed plc's (LON:ERGO) Intrinsic Value Is Potentially 20% Below Its Share Price
Dec 13We Think Ergomed's (LON:ERGO) Statutory Profit Might Understate Its Earnings Potential
Nov 23Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if ERGO's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ERGO's dividend payments have been increasing.
Dividend Yield vs Market
| Ergomed Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (ERGO) | n/a |
| Market Bottom 25% (GB) | 2.1% |
| Market Top 25% (GB) | 5.8% |
| Industry Average (Life Sciences) | 0.7% |
| Analyst forecast (ERGO) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate ERGO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ERGO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate ERGO's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as ERGO has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/11/13 07:19 |
| End of Day Share Price | 2023/11/13 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ergomed plc is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Samuel England | Berenberg |
| Colin Grant | Davy |
| Jonas Peciulis | Edison Investment Research |